This escalation pattern is consistent with other GLP-1 receptor agonists and should be considered when designing preclinical study protocols that aim to replicate clinical pharmacokinetics
Lindgren O, Pacini G, Tura A, Holst JJ, Deacon CF, Ahren B (2015) Incretin effect after oral amino acid ingestion in humans
Interestingly, many patients tell me they begin craving protein and whole foods instead
Dr Wong said that rare but serious side effects, such as acute pancreatitis, have also been reported, although causality has not been definitively established
Why Some Patients Stay at Step 1 on Tirzepatide Tirzepatide is a dual GLP-1/GIP receptor agonist studied for chronic weight management at FDA-approved doses of 2.5 to 15 mg weekly